GW’s Epidiolex results are worth mentioning

Whenever one of my biotech companies have good news. It almost always makes me smile. Yesterday it was GW. The shares of GW Pharmaceuticals (GWPH) are soaring on news that its cannabis-derived drug significantly diminished the seizure amount in children with a rare form of epilepsy in a phase-three trial. Epidiolex…

Continue reading

Porto Update 19-11-2015

Finally an update. These are my stock as per this month. So far it has not been a very good year. Most “winners” were already running last year and I have had to sell the worst “losers”. It was a really busy tent rental season so I didn’t have much…

Continue reading

OCAT – Q3 2015 – Results are in.

View: Annual Data | Quarterly Data All numbers in thousands Period Ending Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Total Revenue 84   39   39   39   Cost of Revenue 16 16 16 16 Gross Profit 69   24   24   24   Operating Expenses Research Development 4,336 3,544 3,378…

Continue reading

Update: December 31st 2014

What can I say? What goes up must come down and that’s what happened. My shifting of funds seemed to pay off but I spoke to soon. It’s a little late now to sell in May (Cliché: 762) but it might turn out to be true this year. I have made…

Continue reading